Bshra A. Alsfouk

1.3k citations

79 papers · 1.0k · h-index 19

Impact in

Toxicology top 1%
- Bioactive Compounds and Antitumor Agents
Organic Chemistry top 5%
- Synthesis and biological activity
- Click Chemistry and Applications

Papers in

Molecular Biology 32
- Angiogenesis and VEGF in Cancer 14
- Cancer therapeutics and mechanisms 6
Organic Chemistry 23
- Synthesis and biological activity 21
- Click Chemistry and Applications 5

Co-authors: Ibrahim H. Eissa (45 shared papers)Ahmed M. Metwaly (45 shared papers)Eslam B. Elkaeed (45 shared papers)Hazem Elkady (27 shared papers)Ibrahim M. Ibrahim (21 shared papers)Dalal Z. Husein (21 shared papers)Reda G. Yousef (13 shared papers)Wagdy M. Eldehna (7 shared papers)
Journals: Molecules (5 papers)RSC Advances (4 papers)Pharmaceuticals (4 papers)Future Medicinal Chemistry (4 papers)Saudi Pharmaceutical Journal (3 papers)
Partner nations: Saudi Arabia Egypt Germany

In The Last Decade

Bshra A. Alsfouk

72 papers receiving 1.0k citations

Peers

Countries citing papers authored by Bshra A. Alsfouk

Since Specialization

Citations

This map shows the geographic impact of Bshra A. Alsfouk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bshra A. Alsfouk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bshra A. Alsfouk more than expected).

Fields of papers citing papers by Bshra A. Alsfouk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bshra A. Alsfouk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bshra A. Alsfouk. The network helps show where Bshra A. Alsfouk may publish in the future.

Co-authors

The 25 scholars most cited alongside Bshra A. Alsfouk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bshra A. Alsfouk Line = papers co-authored together Bshra A. Alsfouk links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects Molecules ·Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, Ibraheem M. M. Gobaara, Bshra A. Alsfouk, Dalal Z. Husein, Ibrahim M. Ibrahim, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	94
2	New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Eslam B. Elkaeed, Mohammed S. Taghour, Hazem A. Mahdy, Wagdy M. Eldehna, Nehal M. El‐Deeb, Ahmed M. Kenawy, Bshra A. Alsfouk, Mohammed A. Dahab, Ahmed M. Metwaly, Ibrahim H. Eissa, Mohamed Ayman El‐Zahabi	2022	60
3	Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy JAMA Neurology ·Bshra A. Alsfouk, Martin J. Brodie, James Walters, Patrick Kwan, Zhibin Chen	2020	54
4	Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs Molecules ·Ibrahim H. Eissa, Mohamed S. Alesawy, Abdulrahman M. Saleh, Eslam B. Elkaeed, Bshra A. Alsfouk, Abdul-Aziz M.M. El-Attar, Ahmed M. Metwaly	2022	43
5	Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies Journal of Biomolecular Structure and Dynamics ·Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, Nehal M. El‐Deeb, Ahmed M. Kenawy, Abeer E. Abd El-Wahab, Eslam B. Elkaeed, Bshra A. Alsfouk, Ahmed M. Metwaly, Ibrahim H. Eissa	2023	41
6	Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway PLoS ONE ·Mohammed S. Taghour, Hazem Elkady, Wagdy M. Eldehna, Nehal M. El‐Deeb, Ahmed M. Kenawy, Eslam B. Elkaeed, Bshra A. Alsfouk, Mohamed S. Alesawy, Dalal Z. Husein, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	40
7	In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivative Journal of Biomolecular Structure and Dynamics ·Eslam B. Elkaeed, Reda G. Yousef, Hazem Elkady, Ahmed B. M. Mehany, Bshra A. Alsfouk, Dalal Z. Husein, Ibrahim M. Ibrahim, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	40
8	New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story Journal of Molecular Structure ·Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, Eslam B. Elkaeed, Dalal Z. Husein, Ibrahim M. Ibrahim, Bshra A. Alsfouk, Ahmed S. Doghish, Hesham A. El‐Mahdy, Ahmed M. Kenawy, Nehal M. El‐Deeb, Ahmed M. Metwaly	2023	39
9	Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies Journal of Enzyme Inhibition and Medicinal Chemistry ·Reda G. Yousef, Alaa Elwan, Ibraheem M. M. Gobaara, Ahmed B. M. Mehany, Wagdy M. Eldehna, Souad A. El‐Metwally, Bshra A. Alsfouk, Eslam B. Elkaeed, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	38
10	Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs Processes ·Eslam B. Elkaeed, Hazem Elkady, Amany Belal, Bshra A. Alsfouk, Tuqa H. Ibrahim, Mohamed Abdelmoaty, Reem K. Arafa, Ahmed M. Metwaly, Ibrahim H. Eissa	2022	36
11	Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies Molecules ·Eslam B. Elkaeed, Reda G. Yousef, Mohamed M. Khalifa, Albaraa Ibrahim, Ahmed B. M. Mehany, Ibraheem M. M. Gobaara, Bshra A. Alsfouk, Wagdy M. Eldehna, Ahmed M. Metwaly, Ibrahim H. Eissa, Mohamed Ayman El‐Zahabi	2022	36
12	Distance Education During COVID-19 Pandemic: A College of Pharmacy Experience Risk Management and Healthcare Policy ·Najla Altwaijry, Alnada Ibrahim, Reem Binsuwaidan, Lina I. Alnajjar, Bshra A. Alsfouk, Raghdah Almutairi	2021	33
13	The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2 Plants ·Ahmed M. Metwaly, Eslam B. Elkaeed, Bshra A. Alsfouk, Abdulrahman M. Saleh, Ahmad E. Mostafa, Ibrahim H. Eissa	2022	29
14	New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations Future Medicinal Chemistry ·Hazem A. Mahdy, Hazem Elkady, Mohammed S. Taghour, Alaa Elwan, Mohammed A. Dahab, Mohamed A. Elkady, Elsayed G.E. Elsakka, Eslam B. Elkaeed, Bshra A. Alsfouk, Ibrahim M. Ibrahim, Ibrahim H. Eissa, Ahmed M. Metwaly	2023	25
15	A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study Life ·Ibrahim H. Eissa, Reda G. Yousef, Hazem Elkady, Aisha A. Alsfouk, Bshra A. Alsfouk, Dalal Z. Husein, Ibrahim M. Ibrahim, Eslam B. Elkaeed, Ahmed M. Metwaly	2023	24
16	Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease Molecules ·E. M. Suleimen, Rani Alphonsa Jose, Raigul N. Suleimen, Christoph Arenz, Margarita Ishmuratova, Suzanne Toppet, Wim Dehaen, Bshra A. Alsfouk, Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly	2022	23
17	Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies RSC Advances ·Walid E. Elgammal, Hazem Elkady, Hazem A. Mahdy, Dalal Z. Husein, Aisha A. Alsfouk, Bshra A. Alsfouk, Ibrahim M. Ibrahim, Eslam B. Elkaeed, Ahmed M. Metwaly, Ibrahim H. Eissa	2023	22
18	Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30‐year longitudinal cohort study Epilepsia ·Bshra A. Alsfouk, Haris Hakeem, Zhibin Chen, James Walters, Martin J. Brodie, Patrick Kwan	2020	21
19	Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors RSC Advances ·Hazem Elkady, Osama A. El-Dardir, Alaa Elwan, Mohammed S. Taghour, Hazem A. Mahdy, Mohammed A. Dahab, Eslam B. Elkaeed, Bshra A. Alsfouk, Ibrahim M. Ibrahim, Dalal Z. Husein, E. S. E. Hafez, Amira M.G. Darwish, Ahmed M. Metwaly, Ibrahim H. Eissa	2023	18
20	Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterum Plants ·E. M. Suleimen, Rani Alphonsa Jose, Gulnur K. Mamytbekova, Raigul N. Suleimen, Margarita Ishmuratova, Wim Dehaen, Bshra A. Alsfouk, Eslam B. Elkaeed, Ibrahim H. Eissa, Ahmed M. Metwaly	2022	18

About Bshra A. Alsfouk

Bshra A. Alsfouk is a scholar working on Molecular Biology, Organic Chemistry, Computational Theory and Mathematics, Pathology and Forensic Medicine and Toxicology, having authored 79 papers that have together received 1.0k indexed citations. Recurring topics across this work include Synthesis and biological activity (21 papers), Computational Drug Discovery Methods (15 papers), Angiogenesis and VEGF in Cancer (14 papers), Cancer Mechanisms and Therapy (12 papers), Bioactive Compounds and Antitumor Agents (11 papers), Epilepsy research and treatment (7 papers), Cancer therapeutics and mechanisms (6 papers) and Click Chemistry and Applications (5 papers). The work is most often cited by research in Toxicology (142 citations), Organic Chemistry (427 citations), Computational Theory and Mathematics (187 citations), Molecular Biology (407 citations) and Pathology and Forensic Medicine (97 citations). Bshra A. Alsfouk has collaborated with scholars based in Saudi Arabia, Egypt and Germany. Frequent co-authors include Ibrahim H. Eissa, Ahmed M. Metwaly, Eslam B. Elkaeed, Hazem Elkady, Ibrahim M. Ibrahim, Dalal Z. Husein, Reda G. Yousef, Wagdy M. Eldehna, Ibraheem M. M. Gobaara and Mohammed S. Taghour. Their work appears in journals such as Molecules, RSC Advances, Pharmaceuticals, Future Medicinal Chemistry and Saudi Pharmaceutical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Bshra A. Alsfouk

Impact in

Papers in i

In The Last Decade

Bshra A. Alsfouk

Peers

Countries citing papers authored by Bshra A. Alsfouk

Fields of papers citing papers by Bshra A. Alsfouk

All Works

About Bshra A. Alsfouk

Explore authors with similar magnitude of impact

Papers in